[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-001", "question": "A 28-year-old male with a history of opioid use disorder presents with syncope. He admits to taking 'massive doses' of an over-the-counter anti-diarrheal medication to manage withdrawal symptoms. ECG shows sinus bradycardia at 45 bpm, a QTc interval of 680 ms, and intermittent broad-complex beats. He is hemodynamically stable but lethargic. Magnesium sulfate 2g IV is administered without change in the rhythm. Which of the following is the most appropriate next step in management?", "options": ["Option A: IV Amiodarone infusion", "Option B: IV Isoproterenol infusion", "Option C: IV Physostigmine", "Option D: Synchronized cardioversion", "Option E: IV Calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The patient has loperamide toxicity, which blocks cardiac sodium and potassium channels, causing QTc prolongation and wide-complex dysrhythmias. Unlike congenital Long QT (where isoproterenol is contraindicated), loperamide-induced TdP/QT prolongation is bradycardia-dependent; increasing the heart rate (chemical or electrical overdrive pacing) shortens the QT interval and prevents Torsades de Pointes. Amiodarone prolongs QT and is contraindicated.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V. Verdict: Correct best answer. The stem describes loperamide-induced cardiotoxicity causing bradycardia-dependent QT prolongation (QTc 680 ms) with Torsades de Pointes risk after ineffective magnesium. Discriminating clues: massive OTC anti-diarrheal ingestion, sinus bradycardia at 45 bpm, intermittent broad-complex beats, and hemodynamic stability. The mechanism requires heart rate acceleration to shorten the QT interval. IV isoproterenol (B) provides chemical overdrive pacing, directly targeting the bradycardia-dependent pathophysiology. Alternatives are correctly excluded: amiodarone (A) prolongs QT; physostigmine (C) treats anticholinergic toxicity; synchronized cardioversion (D) is for unstable tachyarrhythmias; calcium gluconate (E) is for hyperkalemia/CCB overdose. The item is logically valid with a single defensible answer and no contradictions. Medical content is accurate per current toxicology and ACLS guidelines for drug-induced TdP. Minor issue: the rationale oversimplifies congenital LQTS management (isoproterenol is not absolutely contraindicated, just less favored). Minimal fix: revise rationale to 'isoproterenol is primarily indicated for acquired bradycardia-dependent TdP, while congenital LQTS is managed with beta-blockers and pacing.'\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem describes loperamide-induced cardiotoxicity causing bradycardia-dependent QT prolongation (QTc 680 ms) with Torsades de Pointes risk after ineffective magnesium. Discriminating clues: massive OTC anti-diarrheal ingestion, sinus bradycardia at 45 bpm, intermittent broad-complex beats, and hemodynamic stability. The mechanism requires heart rate acceleration to shorten the QT interval. IV isoproterenol (B) provides chemical overdrive pacing, directly targeting the bradycardia-dependent pathophysiology. Alternatives are correctly excluded: amiodarone (A) prolongs QT; physostigmine (C) treats anticholinergic toxicity; synchronized cardioversion (D) is for unstable tachyarrhythmias; calcium gluconate (E) is for hyperkalemia/CCB overdose. The item is logically valid with a single defensible answer and no contradictions. Medical content is accurate per current toxicology and ACLS guidelines for drug-induced TdP. Minor issue: the rationale oversimplifies congenital LQTS management (isoproterenol is not absolutely contraindicated, just less favored). Minimal fix: revise rationale to 'isoproterenol is primarily indicated for acquired bradycardia-dependent TdP, while congenital LQTS is managed with beta-blockers and pacing.'", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-002", "question": "A 4-month-old female presents with failure to thrive, hypotonia, and a history of pyridoxine-responsive seizures. Laboratory evaluation reveals hypercalcemia, hypercalciuria, and a suppressed parathyroid hormone (PTH) level. Skeletal survey demonstrates diffuse demineralization and 'moth-eaten' radiolucencies at the metaphyses. Serum alkaline phosphatase (ALP) is 15 IU/L (Reference: 150-420 IU/L). Which of the following is the definitive treatment for this condition?", "options": ["Option A: High-dose Vitamin D supplementation", "Option B: Recombinant human parathyroid hormone (Teriparatide)", "Option C: Asfotase alfa", "Option D: Pyridoxine (Vitamin B6) monotherapy", "Option E: Bisphosphonate therapy"], "answer": "C", "answer_index": 2, "explanation": "The diagnosis is Hypophosphatasia (HPP), caused by a loss-of-function mutation in the ALPL gene encoding tissue-nonspecific alkaline phosphatase (TNSALP). Low ALP leads to accumulation of inorganic pyrophosphate (an inhibitor of bone mineralization) and pyridoxal-5'-phosphate (causing B6-dependent seizures due to lack of dephosphorylation). Asfotase alfa is the enzyme replacement therapy. Vitamin D and bisphosphonates are contraindicated as they may worsen hypercalcemia and inhibit mineralization further.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem's constellation of infantile failure to thrive, hypotonia, pyridoxine-responsive seizures, hypercalcemia with suppressed PTH, radiographic demineralization with metaphyseal 'moth-eaten' lesions, and critically low ALP (15 IU/L) is pathognomonic for infantile hypophosphatasia (HPP). Asfotase alfa, a recombinant tissue-nonspecific alkaline phosphatase, is the FDA-approved enzyme replacement therapy and definitive treatment for HPP, directly addressing the underlying ALPL enzyme deficiency. Alternative options are appropriately excluded: vitamin D supplementation (A) and bisphosphonates (E) are contraindicated due to risk of worsening hypercalcemia and further impairing mineralization; teriparatide (B) is ineffective and illogical with suppressed PTH; pyridoxine monotherapy (D) only addresses seizures symptomatically, not the skeletal disease. No logical flaws, contradictions, or ambiguities exist; a single best answer is clearly defensible. Medical content aligns precisely with current consensus and orphan-drug approval data. Minor enhancement could include specifying 'perinatal/infantile-onset HPP' for absolute clarity, but this is unnecessary for answer discrimination.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem's constellation of infantile failure to thrive, hypotonia, pyridoxine-responsive seizures, hypercalcemia with suppressed PTH, radiographic demineralization with metaphyseal 'moth-eaten' lesions, and critically low ALP (15 IU/L) is pathognomonic for infantile hypophosphatasia (HPP). Asfotase alfa, a recombinant tissue-nonspecific alkaline phosphatase, is the FDA-approved enzyme replacement therapy and definitive treatment for HPP, directly addressing the underlying ALPL enzyme deficiency. Alternative options are appropriately excluded: vitamin D supplementation (A) and bisphosphonates (E) are contraindicated due to risk of worsening hypercalcemia and further impairing mineralization; teriparatide (B) is ineffective and illogical with suppressed PTH; pyridoxine monotherapy (D) only addresses seizures symptomatically, not the skeletal disease. No logical flaws, contradictions, or ambiguities exist; a single best answer is clearly defensible. Medical content aligns precisely with current consensus and orphan-drug approval data. Minor enhancement could include specifying 'perinatal/infantile-onset HPP' for absolute clarity, but this is unnecessary for answer discrimination.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-003", "question": "A 68-year-old male presents with recurrent fevers, painful auricular chondritis, pulmonary infiltrates, and macrocytic anemia. He has been treated for 'refractory relapsing polychondritis' without success. Bone marrow biopsy reveals hypercellularity with prominent cytoplasmic vacuoles in myeloid and erythroid precursor cells. Which of the following is the most likely diagnosis?", "options": ["Option A: Myelodysplastic Syndrome (MDS) with excess blasts", "Option B: VEXAS syndrome", "Option C: Sweet syndrome", "Option D: Polyarteritis Nodosa", "Option E: Granulomatosis with Polyangiitis"], "answer": "B", "answer_index": 1, "explanation": "VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a recently described disorder caused by somatic mutations in the UBA1 gene. It presents in older men with inflammatory features (chondritis, vasculitis, fevers) and hematologic abnormalities (macrocytic anemia). The pathognomonic finding is vacuoles in myeloid and erythroid precursors in the bone marrow.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"VEXAS syndrome is the unique best answer for a 68-year-old man with refractory inflammatory chondritis, fevers, pulmonary infiltrates, macrocytic anemia, and pathognomonic cytoplasmic vacuoles in myeloid/erythroid precursors on bone marrow biopsy. The stem provides the classic triad of VEXAS: (1) late-onset systemic inflammation mimicking relapsing polychondritis, (2) macrocytic anemia, and (3) characteristic bone marrow vacuolization—findings not seen together in any alternative. Alternative analysis: MDS with excess blasts (A) would show increased blasts and lacks inflammatory chondritis; Sweet syndrome (C) is a skin-limited neutrophilic dermatosis without marrow vacuoles; PAN (D) and GPA (E) are vasculitides that do not cause macrocytic anemia or marrow vacuoles. Logical validity: V (Valid). The stem contains sufficient discriminating detail to select a single best answer, and the key matches. No contradictions or underspecification. Medical accuracy: Gold standard. VEXAS syndrome (UBA1 somatic mutation) is a recognized entity (2020) with precisely the described features; the bone marrow finding is pathognomonic. No inaccuracies or outdated concepts. Minimal fix: None required; item is board-ready.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "VEXAS syndrome is the unique best answer for a 68-year-old man with refractory inflammatory chondritis, fevers, pulmonary infiltrates, macrocytic anemia, and pathognomonic cytoplasmic vacuoles in myeloid/erythroid precursors on bone marrow biopsy. The stem provides the classic triad of VEXAS: (1) late-onset systemic inflammation mimicking relapsing polychondritis, (2) macrocytic anemia, and (3) characteristic bone marrow vacuolization—findings not seen together in any alternative. Alternative analysis: MDS with excess blasts (A) would show increased blasts and lacks inflammatory chondritis; Sweet syndrome (C) is a skin-limited neutrophilic dermatosis without marrow vacuoles; PAN (D) and GPA (E) are vasculitides that do not cause macrocytic anemia or marrow vacuoles. Logical validity: V (Valid). The stem contains sufficient discriminating detail to select a single best answer, and the key matches. No contradictions or underspecification. Medical accuracy: Gold standard. VEXAS syndrome (UBA1 somatic mutation) is a recognized entity (2020) with precisely the described features; the bone marrow finding is pathognomonic. No inaccuracies or outdated concepts. Minimal fix: None required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-004", "question": "A 55-year-old female with chronic malnutrition and a history of chronic acetaminophen use for osteoarthritis presents with altered mental status. Arterial blood gas shows pH 7.28, pCO2 28 mmHg, HCO3 12 mEq/L. The anion gap is 24. Lactate is 0.9 mmol/L, serum ketones are negative, and creatinine is 1.1 mg/dL. Toxic alcohol screen is negative. Which of the following is the most appropriate therapeutic intervention?", "options": ["Option A: IV Fomepizole", "Option B: IV Sodium Bicarbonate", "Option C: N-acetylcysteine", "Option D: Hemodialysis", "Option E: Thiamine and Dextrose"], "answer": "C", "answer_index": 2, "explanation": "This patient has high anion gap metabolic acidosis due to 5-oxoproline (pyroglutamic acid) accumulation. This occurs in the setting of glutathione depletion (malnutrition, acetaminophen use), which disrupts the gamma-glutamyl cycle. N-acetylcysteine replenishes glutathione stores, restoring the feedback loop and halting 5-oxoproline production. Fomepizole is for toxic alcohols, which were ruled out.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: The keyed answer C (N‑acetylcysteine) is the correct best answer. Key stem clues: chronic malnutrition and chronic acetaminophen use are classic risk factors for 5‑oxoproline (pyroglutamic acid) accumulation; a high anion‑gap metabolic acidosis (pH 7.28, HCO3 12 mEq/L, anion gap 24) with normal lactate, negative ketones, and a negative toxic alcohol screen effectively rules out lactic acidosis, ketoacidosis, and toxic alcohol ingestion; normal creatinine excludes renal failure as the cause. These findings uniquely point to 5‑oxoproline acidosis. N‑acetylcysteine restores glutathione, correcting the underlying γ‑glutamyl cycle defect and halting further 5‑oxoproline production. Alternative options are clearly inferior: fomepizole is indicated only for toxic alcohols (already excluded); sodium bicarbonate treats the symptom rather than the etiology and is not required for a pH of 7.28; hemodialysis is not routinely recommended because 5‑oxoproline is not a dialyzable toxin and renal function is intact; thiamine/dextrose addresses unrelated conditions (Wernicke’s, alcohol withdrawal). No internal contradictions or missing critical data; a single best answer is defensible. Medical accuracy: The pathophysiology and treatment align with current literature and board expectations. No safety concerns. Minimal fix: None required.\",\n\"medical_accuracy_score\":  \t \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: The keyed answer C (N‑acetylcysteine) is the correct best answer. Key stem clues: chronic malnutrition and chronic acetaminophen use are classic risk factors for 5‑oxoproline (pyroglutamic acid) accumulation; a high anion‑gap metabolic acidosis (pH 7.28, HCO3 12 mEq/L, anion gap 24) with normal lactate, negative ketones, and a negative toxic alcohol screen effectively rules out lactic acidosis, ketoacidosis, and toxic alcohol ingestion; normal creatinine excludes renal failure as the cause. These findings uniquely point to 5‑oxoproline acidosis. N‑acetylcysteine restores glutathione, correcting the underlying γ‑glutamyl cycle defect and halting further 5‑oxoproline production. Alternative options are clearly inferior: fomepizole is indicated only for toxic alcohols (already excluded); sodium bicarbonate treats the symptom rather than the etiology and is not required for a pH of 7.28; hemodialysis is not routinely recommended because 5‑oxoproline is not a dialyzable toxin and renal function is intact; thiamine/dextrose addresses unrelated conditions (Wernicke’s, alcohol withdrawal). No internal contradictions or missing critical data; a single best answer is defensible. Medical accuracy: The pathophysiology and treatment align with current literature and board expectations. No safety concerns. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-005", "question": "A 32-year-old female presents with amenorrhea and galactorrhea. MRI reveals a 4.5 cm pituitary macroadenoma with invasion into the cavernous sinus. Visual fields are intact. Serum prolactin is reported as 145 ng/mL (Reference: <25 ng/mL). Which of the following is the most appropriate next step in management?", "options": ["Option A: Referral for transsphenoidal resection", "Option B: Stereotactic radiosurgery", "Option C: Measurement of prolactin in diluted serum", "Option D: Octreotide scintigraphy", "Option E: Bilateral inferior petrosal sinus sampling"], "answer": "C", "answer_index": 2, "explanation": "A 4.5 cm prolactinoma should typically produce prolactin levels >1,000-10,000 ng/mL. A mildly elevated level in the setting of a giant adenoma suggests the 'Hook Effect,' where excessive antigen saturates the assay antibodies, preventing sandwich formation and leading to a falsely low result. Diluting the sample (1:100) reveals the true elevated value. Confirming a prolactinoma is crucial because dopamine agonists (cabergoline) are the first-line treatment, not surgery.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. Key stem clues: 4.5 cm macroadenoma with cavernous sinus invasion, amenorrhea/galactorrhea, and prolactin of only 145 ng/mL (should be >1,000 ng/mL). This discrepancy signals the hook effect, where excess antigen saturates immunoassay antibodies, yielding falsely low results. Option C (diluted prolactin measurement) directly confirms this artifact and establishes true hormone elevation before treatment. Alternatives are indefensible: surgery (A) and radiosurgery (B) are not first-line without vision compromise; octreotide scintigraphy (D) is for somatostatin receptor-positive adenomas (GH/TSH), not prolactinomas; inferior petrosal sinus sampling (E) diagnoses ACTH-dependent Cushing's. No logical issues: single best answer is clear, key is correct, and options permit discrimination. Medical accuracy is gold-standard: hook effect is well-established, expected prolactin levels are accurate, and the implied dopamine agonist-first approach aligns with Endocrine Society guidelines. Minimal fix: None; item is board-ready.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. Key stem clues: 4.5 cm macroadenoma with cavernous sinus invasion, amenorrhea/galactorrhea, and prolactin of only 145 ng/mL (should be >1,000 ng/mL). This discrepancy signals the hook effect, where excess antigen saturates immunoassay antibodies, yielding falsely low results. Option C (diluted prolactin measurement) directly confirms this artifact and establishes true hormone elevation before treatment. Alternatives are indefensible: surgery (A) and radiosurgery (B) are not first-line without vision compromise; octreotide scintigraphy (D) is for somatostatin receptor-positive adenomas (GH/TSH), not prolactinomas; inferior petrosal sinus sampling (E) diagnoses ACTH-dependent Cushing's. No logical issues: single best answer is clear, key is correct, and options permit discrimination. Medical accuracy is gold-standard: hook effect is well-established, expected prolactin levels are accurate, and the implied dopamine agonist-first approach aligns with Endocrine Society guidelines. Minimal fix: None; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-006", "question": "A 60-year-old male with a history of radiation therapy for Hodgkin lymphoma presents with signs of cardiac tamponade. Pericardiocentesis is performed, draining 800 mL of bloody fluid. Following drainage, the intrapericardial pressure drops to 0 mmHg, but the right atrial pressure remains elevated at 18 mmHg with a prominent y-descent that was previously absent. Which of the following is the most likely diagnosis?", "options": ["Option A: Incomplete drainage of the effusion", "Option B: Effusive-constrictive pericarditis", "Option C: Right ventricular infarction", "Option D: Pulmonary embolism", "Option E: Flash pulmonary edema"], "answer": "B", "answer_index": 1, "explanation": "Effusive-constrictive pericarditis is characterized by concurrent tamponade and constriction. The visceral pericardium is thickened and constrictive. Initially, the effusion masks the constriction (tamponade physiology: blunted y-descent). After drainage, the tamponade resolves, but the underlying constriction becomes manifest (elevated RA pressure with prominent y-descent). Treatment requires visceral pericardiectomy.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict on keyed answer: Correct best answer. Key stem clues driving the diagnosis: (1) prior mediastinal radiation, a classic cause of constrictive pericarditis; (2) normalization of intrapericardial pressure to 0 mmHg after drainage, ruling out incomplete evacuation; (3) persistent elevation of right atrial pressure at 18 mmHg despite decompression; and (4) emergence of a prominent y-descent only after fluid removal—pathognomonic for constrictive physiology unmasked when tamponade resolves. Each alternative is definitively excluded: Option A is inconsistent with normalized intrapericardial pressure; Option C lacks supporting ECG or hemodynamic patterns; Option D would present acutely with hypoxia and tachycardia rather than isolated RA pressure changes; Option E involves left-sided failure, not isolated right atrial elevation. No logical flaws or internal contradictions exist. Medical accuracy is exemplary: the hemodynamic progression from tamponade (blunted y-descent) to constriction (prominent y-descent) is precisely described, radiation-induced etiology is appropriate, and the recommended visceral pericardiectomy aligns with guidelines. Minor enhancement could specify the exact timing of pressure measurements relative to drainage, but this does not affect answer selection. The item is board-caliber as written.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict on keyed answer: Correct best answer. Key stem clues driving the diagnosis: (1) prior mediastinal radiation, a classic cause of constrictive pericarditis; (2) normalization of intrapericardial pressure to 0 mmHg after drainage, ruling out incomplete evacuation; (3) persistent elevation of right atrial pressure at 18 mmHg despite decompression; and (4) emergence of a prominent y-descent only after fluid removal—pathognomonic for constrictive physiology unmasked when tamponade resolves. Each alternative is definitively excluded: Option A is inconsistent with normalized intrapericardial pressure; Option C lacks supporting ECG or hemodynamic patterns; Option D would present acutely with hypoxia and tachycardia rather than isolated RA pressure changes; Option E involves left-sided failure, not isolated right atrial elevation. No logical flaws or internal contradictions exist. Medical accuracy is exemplary: the hemodynamic progression from tamponade (blunted y-descent) to constriction (prominent y-descent) is precisely described, radiation-induced etiology is appropriate, and the recommended visceral pericardiectomy aligns with guidelines. Minor enhancement could specify the exact timing of pressure measurements relative to drainage, but this does not affect answer selection. The item is board-caliber as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-007", "question": "A 65-year-old male is admitted to the ICU for sedation and mechanical ventilation. On day 3 of a continuous propofol infusion, he develops new Right Bundle Branch Block with coved ST-segment elevation in leads V1-V3. Labs reveal severe metabolic acidosis (pH 7.18), Lactate 9 mmol/L, and CK 8,000 U/L. Echocardiogram shows new global hypokinesis. Which of the following is the most likely diagnosis?", "options": ["Option A: Acute Anterior ST-Elevation MI", "Option B: Massive Pulmonary Embolism", "Option C: Propofol Infusion Syndrome", "Option D: Brugada Syndrome unmasked by fever", "Option E: Septic Cardiomyopathy"], "answer": "C", "answer_index": 2, "explanation": "Propofol Infusion Syndrome (PRIS) is a rare but lethal complication of high-dose/long-duration propofol. It causes mitochondrial failure leading to rhabdomyolysis, metabolic acidosis, heart failure, and characteristic ECG changes (often Brugada-like pattern: RBBB with coved ST elevation). Immediate cessation of propofol and supportive care is required.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem presents a classic, board-style vignette of Propofol Infusion Syndrome (PRIS) with complete diagnostic criteria: prolonged high-dose propofol exposure (3-day continuous infusion), severe metabolic acidosis (pH 7.18), hyperlactatemia (9 mmol/L), profound rhabdomyolysis (CK 8,000 U/L), acute biventricular failure (new global hypokinesis), and pathognomonic Brugada-like ECG changes (RBBB with coved ST elevation in V1-V3). This constellation uniquely defines PRIS-mediated mitochondrial toxicity. Distractors are appropriately excluded: anterior STEMI cannot explain rhabdomyolysis or isolated CK elevation; massive PE lacks the metabolic profile and characteristic ECG morphology; Brugada syndrome unmasked by fever is inconsistent with absent fever and the systemic metabolic derangements; septic cardiomyopathy does not produce rhabdomyolysis or Brugada patterns. No logical flaws, missing critical details, or internal contradictions exist. Medical content is fully accurate, aligns with current ICU pharmacology and toxicology standards, and represents ideal board-level material. No revisions required.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem presents a classic, board-style vignette of Propofol Infusion Syndrome (PRIS) with complete diagnostic criteria: prolonged high-dose propofol exposure (3-day continuous infusion), severe metabolic acidosis (pH 7.18), hyperlactatemia (9 mmol/L), profound rhabdomyolysis (CK 8,000 U/L), acute biventricular failure (new global hypokinesis), and pathognomonic Brugada-like ECG changes (RBBB with coved ST elevation in V1-V3). This constellation uniquely defines PRIS-mediated mitochondrial toxicity. Distractors are appropriately excluded: anterior STEMI cannot explain rhabdomyolysis or isolated CK elevation; massive PE lacks the metabolic profile and characteristic ECG morphology; Brugada syndrome unmasked by fever is inconsistent with absent fever and the systemic metabolic derangements; septic cardiomyopathy does not produce rhabdomyolysis or Brugada patterns. No logical flaws, missing critical details, or internal contradictions exist. Medical content is fully accurate, aligns with current ICU pharmacology and toxicology standards, and represents ideal board-level material. No revisions required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-008", "question": "A 58-year-old male with dyslipidemia develops proximal muscle weakness and myalgias. His CK is 8,500 U/L. Atorvastatin is discontinued. Two months later, his weakness has progressed, and CK remains elevated at 9,200 U/L. Muscle biopsy shows necrotizing myopathy with minimal inflammation. Testing for anti-HMGCR antibodies is positive. Which of the following is the most appropriate management?", "options": ["Option A: Switch to Rosuvastatin", "Option B: Initiate Coenzyme Q10 supplementation", "Option C: Initiate IVIG and/or systemic immunosuppression", "Option D: Observation for spontaneous resolution", "Option E: Dantrolene sodium"], "answer": "C", "answer_index": 2, "explanation": "This patient has Statin-Associated Autoimmune Myopathy (SAAM), specifically anti-HMGCR positive necrotizing myopathy. Unlike self-limited statin myotoxicity, this is an autoimmune process that progresses despite statin cessation. It requires aggressive immunosuppression (steroids, IVIG, Rituximab, or Methotrexate) to prevent permanent muscle loss.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The vignette provides classic features of anti-HMGCR statin-associated autoimmune necrotizing myopathy (SANAM): severe/progressive proximal weakness, CK >8,000 U/L persisting 2 months after statin discontinuation, necrotizing myopathy with minimal inflammation on biopsy, and positive anti-HMGCR antibodies. These clues uniquely point to an autoimmune process requiring immunosuppression, not simple statin intolerance. Keyed answer C (IVIG and/or systemic immunosuppression) is the definitive best choice, consistent with ACR/EULAR guidelines recommending high-dose glucocorticoids as first-line, with IVIG, methotrexate, or rituximab for refractory/severe disease. Alternative options are correctly discriminable: switching to rosuvastatin (A) or CoQ10 (B) would not address autoimmunity; observation (D) would allow irreversible muscle damage; dantrolene (E) is mechanistically irrelevant. No internal contradictions or critical omissions exist. Medical accuracy is excellent—entity recognition, diagnostic workup, and management align with current consensus. The 'and/or' phrasing appropriately captures treatment flexibility. No logical or medical flaws require correction; item is board-ready.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The vignette provides classic features of anti-HMGCR statin-associated autoimmune necrotizing myopathy (SANAM): severe/progressive proximal weakness, CK >8,000 U/L persisting 2 months after statin discontinuation, necrotizing myopathy with minimal inflammation on biopsy, and positive anti-HMGCR antibodies. These clues uniquely point to an autoimmune process requiring immunosuppression, not simple statin intolerance. Keyed answer C (IVIG and/or systemic immunosuppression) is the definitive best choice, consistent with ACR/EULAR guidelines recommending high-dose glucocorticoids as first-line, with IVIG, methotrexate, or rituximab for refractory/severe disease. Alternative options are correctly discriminable: switching to rosuvastatin (A) or CoQ10 (B) would not address autoimmunity; observation (D) would allow irreversible muscle damage; dantrolene (E) is mechanistically irrelevant. No internal contradictions or critical omissions exist. Medical accuracy is excellent—entity recognition, diagnostic workup, and management align with current consensus. The 'and/or' phrasing appropriately captures treatment flexibility. No logical or medical flaws require correction; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-009", "question": "A 2-week-old XX infant presents with ambiguous genitalia (virilization). Vital signs reveal a blood pressure of 96/60 mmHg (hypertensive for age). Laboratory evaluation shows Sodium 136 mEq/L and Potassium 2.9 mEq/L. 17-hydroxyprogesterone is elevated. Which of the following enzyme deficiencies is the most likely cause?", "options": ["Option A: 21-hydroxylase deficiency", "Option B: 11-beta-hydroxylase deficiency", "Option C: 17-alpha-hydroxylase deficiency", "Option D: 3-beta-hydroxysteroid dehydrogenase deficiency", "Option E: P450 oxidoreductase deficiency"], "answer": "B", "answer_index": 1, "explanation": "Congenital Adrenal Hyperplasia due to 11-beta-hydroxylase deficiency blocks cortisol synthesis, shunting precursors to androgens (causing virilization in females) and accumulating 11-deoxycorticosterone (DOC). DOC is a potent mineralocorticoid, leading to salt retention, hypertension, and hypokalemia. This distinguishes it from the more common 21-hydroxylase deficiency, which causes salt-wasting (hypotension, hyperkalemia).", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. Key stem clues: 2-week-old XX infant with virilization; hypertension (BP 96/60 mmHg) and hypokalemia (K+ 2.9 mEq/L) indicating mineralocorticoid excess; elevated 17-hydroxyprogesterone confirming adrenal hyperplasia. These findings point to 11β‑hydroxylase deficiency, where blockade of cortisol synthesis shunts precursors to androgens (virilization) and 11‑deoxycorticosterone (DOC) accumulates, causing salt retention, hypertension, and hypokalemia. Alternative diagnoses are inconsistent: 21‑hydroxylase deficiency produces salt‑wasting (hypotension, hyperkalemia); 17α‑hydroxylase deficiency lacks virilization and lowers 17‑OHP; 3β‑HSD deficiency does not raise 17‑OHP; P450 oxidoreductase deficiency lacks the mineralocorticoid excess phenotype. No internal contradictions; a single best answer is supported and matches the key. Medical accuracy: the vignette and explanation align with current endocrine consensus and board expectations. Minimal fix: none required.\",\n\"medical_accuracy_score\":  \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: 2-week-old XX infant with virilization; hypertension (BP 96/60 mmHg) and hypokalemia (K+ 2.9 mEq/L) indicating mineralocorticoid excess; elevated 17-hydroxyprogesterone confirming adrenal hyperplasia. These findings point to 11β‑hydroxylase deficiency, where blockade of cortisol synthesis shunts precursors to androgens (virilization) and 11‑deoxycorticosterone (DOC) accumulates, causing salt retention, hypertension, and hypokalemia. Alternative diagnoses are inconsistent: 21‑hydroxylase deficiency produces salt‑wasting (hypotension, hyperkalemia); 17α‑hydroxylase deficiency lacks virilization and lowers 17‑OHP; 3β‑HSD deficiency does not raise 17‑OHP; P450 oxidoreductase deficiency lacks the mineralocorticoid excess phenotype. No internal contradictions; a single best answer is supported and matches the key. Medical accuracy: the vignette and explanation align with current endocrine consensus and board expectations. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-010", "question": "A 45-year-old male on chronic amiodarone therapy for atrial fibrillation presents with weight loss and palpitations. TSH is <0.01 mIU/L and Free T4 is elevated. He has no neck pain. Thyroid ultrasound with color flow Doppler reveals an absence of vascularity within the thyroid parenchyma. Which of the following is the most appropriate initial treatment?", "options": ["Option A: Methimazole", "Option B: Propylthiouracil", "Option C: Prednisone", "Option D: Radioactive Iodine ablation", "Option E: Potassium Perchlorate"], "answer": "C", "answer_index": 2, "explanation": "This is Type 2 Amiodarone-Induced Thyrotoxicosis (AIT), which is a destructive thyroiditis caused by direct cytotoxic effects of the drug. The key differentiator from Type 1 AIT (Jod-Basedow/iodine-induced synthesis) is the Doppler flow: Type 1 has increased vascularity, while Type 2 has absent vascularity. Type 2 is treated with high-dose glucocorticoids. Thionamides (Methimazole) are ineffective for destructive thyroiditis.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. Key stem clues: chronic amiodarone therapy, suppressed TSH with elevated Free T4, absent Doppler vascularity, and lack of neck pain collectively identify Type 2 amiodarone-induced thyrotoxicosis (AIT)—a destructive thyroiditis. The absent vascularity is the critical discriminator from Type 1 AIT (increased flow). The keyed answer C (Prednisone) represents standard high-dose glucocorticoid therapy for Type 2 AIT, reducing inflammatory hormone release and restoring euthyroidism within weeks. Alternative options are correctly excluded: thionamides (A, B) block synthesis and are ineffective for destructive processes; radioactive iodine (D) is futile due to iodine saturation and low uptake; potassium perchlorate (E) is nonstandard and potentially hazardous with limited evidence. No logical flaws exist: the vignette yields a single diagnostic entity with one evidence-based treatment. Medical accuracy is gold-standard, fully consistent with current endocrine society/ATA guidelines and clinical trials. Minimal fix: none required; the item is board-examination ready as written.\",\"medical_accuracy_score\":    \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. Key stem clues: chronic amiodarone therapy, suppressed TSH with elevated Free T4, absent Doppler vascularity, and lack of neck pain collectively identify Type 2 amiodarone-induced thyrotoxicosis (AIT)—a destructive thyroiditis. The absent vascularity is the critical discriminator from Type 1 AIT (increased flow). The keyed answer C (Prednisone) represents standard high-dose glucocorticoid therapy for Type 2 AIT, reducing inflammatory hormone release and restoring euthyroidism within weeks. Alternative options are correctly excluded: thionamides (A, B) block synthesis and are ineffective for destructive processes; radioactive iodine (D) is futile due to iodine saturation and low uptake; potassium perchlorate (E) is nonstandard and potentially hazardous with limited evidence. No logical flaws exist: the vignette yields a single diagnostic entity with one evidence-based treatment. Medical accuracy is gold-standard, fully consistent with current endocrine society/ATA guidelines and clinical trials. Minimal fix: none required; the item is board-examination ready as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]